E Stahel, A Degrémont, U Lagler. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultDrug Combinations/pharmacologyDrug ResistanceHumansMalePlasmodium falciparum/drug effectsPyrimethamine/pharmacologySulfadoxine/pharmacologySulfanilamides/pharmacologyTanzania
Substances: See more » Drug CombinationsSulfanilamidesfanasil, pyrimethamine drug combinationSulfadoxinePyrimethamine
Year: 1982 PMID: 6122905 DOI: 10.1016/s0140-6736(82)92294-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321